Table 7 Univariate and multivariate survival analyses of AC087388.1, SLC16A1-AS1, and ELFN1-AS1
From: Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma
AC087388 | SLC16A1-AS1 | ELFN1-AS1 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Multivariate analysis | Multivariate analysis | |||||||||||||
HR | 95% CI | Pvalue | HR | 95% CI | Pvalue | HR | 95% CI | Pvalue | HR | 95% CI | Pvalue | |||||
ENSG00000262251 | 1.45 | 1.14 | 1.85 | 0.00 | 1.53 | 1.01 | 2.31 | 0.04 | ||||||||
ENSG00000226419 | 1.22 | 1.01 | 1.47 | 0.04 | 1.95 | 1.27 | 3.00 | 0.00 | ||||||||
ENSG00000236081 | 1.15 | 1.01 | 1.31 | 0.04 | 1.86 | 1.23 | 2.81 | 0.00 | ||||||||
Stage1&2/3&4 | 2.73 | 1.80 | 4.15 | 0.00 | 1.68 | 0.96 | 2.91 | 0.07 | 1.58 | 0.90 | 2.76 | 0.11 | 1.64 | 0.95 | 2.85 | 0.08 |
Pathologic_T (T1&2/T3&4) | 2.95 | 1.37 | 6.37 | 0.01 | 2.20 | 0.86 | 5.63 | 0.10 | 2.42 | 0.95 | 6.19 | 0.06 | 2.38 | 0.93 | 6.07 | 0.07 |
pathologic_M (M0/Mx) | 3.12 | 2.08 | 4.68 | 0.00 | 2.15 | 1.36 | 3.40 | 0.00 | 2.26 | 1.43 | 3.57 | 0.00 | 2.34 | 1.49 | 3.70 | 0.00 |
Pathologic_N (N0&1/N2) | 3.28 | 2.19 | 4.93 | 0.00 | 1.71 | 1.03 | 2.82 | 0.04 | 1.65 | 1.00 | 2.73 | 0.05 | 1.68 | 1.01 | 2.79 | 0.04 |
Sex (Female/Male) | 1.09 | 0.74 | 1.61 | 0.68 | 0.93 | 0.62 | 1.41 | 0.73 | 0.92 | 0.61 | 1.39 | 0.69 | 0.90 | 0.59 | 1.36 | 0.61 |
Age (≤65/> 65) | 1.76 | 1.18 | 2.63 | 0.01 | 2.25 | 1.46 | 3.48 | 0.00 | 2.49 | 1.61 | 3.86 | 0.00 | 2.29 | 1.49 | 3.54 | 0.00 |